Healthy minds 0–100 years: Optimising the use of European brain imaging cohorts (“Lifebrain”)

Kristine B. Walhovd, Anders M. Fjell, René Westerhausen, Lars Nyberg, Klaus P. Ebmeier, Ulman Lindenberger, David Bartrés-Faz, William F.C. Baaré, Hartwig R. Siebner, Richard Henson, Christian A. Drevon, Gun Peggy Strømstad Knudsen, Isabelle Budin Ljøsne, Brenda W.J.H. Penninx, Paolo Ghisletta, Ole Rogeberg, Lorraine Tyler, Lars Bertram, Lifebrain Consortium

Research output: Contribution to journalShort surveyAcademicpeer-review

Abstract

The main objective of “Lifebrain” is to identify the determinants of brain, cognitive and mental (BCM) health at different stages of life. By integrating, harmonising and enriching major European neuroimaging studies across the life span, we will merge fine-grained BCM health measures of more than 5000 individuals. Longitudinal brain imaging, genetic and health data are available for a major part, as well as cognitive and mental health measures for the broader cohorts, exceeding 27,000 examinations in total. By linking these data to other databases and biobanks, including birth registries, national and regional archives, and by enriching them with a new online data collection and novel measures, we will address the risk factors and protective factors of BCM health. We will identify pathways through which risk and protective factors work and their moderators. Exploiting existing European infrastructures and initiatives, we hope to make major conceptual, methodological and analytical contributions towards large integrative cohorts and their efficient exploitation. We will thus provide novel information on BCM health maintenance, as well as the onset and course of BCM disorders. This will lay a foundation for earlier diagnosis of brain disorders, aberrant development and decline of BCM health, and translate into future preventive and therapeutic strategies. Aiming to improve clinical practice and public health we will work with stakeholders and health authorities, and thus provide the evidence base for prevention and intervention.

Original languageEnglish
Pages (from-to)47-56
Number of pages10
JournalEuropean Psychiatry
Volume50
DOIs
Publication statusPublished - 1 Apr 2018

Cite this

Walhovd, K. B., Fjell, A. M., Westerhausen, R., Nyberg, L., Ebmeier, K. P., Lindenberger, U., ... Lifebrain Consortium (2018). Healthy minds 0–100 years: Optimising the use of European brain imaging cohorts (“Lifebrain”). European Psychiatry, 50, 47-56. https://doi.org/10.1016/j.eurpsy.2017.12.006
Walhovd, Kristine B. ; Fjell, Anders M. ; Westerhausen, René ; Nyberg, Lars ; Ebmeier, Klaus P. ; Lindenberger, Ulman ; Bartrés-Faz, David ; Baaré, William F.C. ; Siebner, Hartwig R. ; Henson, Richard ; Drevon, Christian A. ; Strømstad Knudsen, Gun Peggy ; Ljøsne, Isabelle Budin ; Penninx, Brenda W.J.H. ; Ghisletta, Paolo ; Rogeberg, Ole ; Tyler, Lorraine ; Bertram, Lars ; Lifebrain Consortium. / Healthy minds 0–100 years : Optimising the use of European brain imaging cohorts (“Lifebrain”). In: European Psychiatry. 2018 ; Vol. 50. pp. 47-56.
@article{9952393fd23543a5873092756487e425,
title = "Healthy minds 0–100 years: Optimising the use of European brain imaging cohorts (“Lifebrain”)",
abstract = "The main objective of “Lifebrain” is to identify the determinants of brain, cognitive and mental (BCM) health at different stages of life. By integrating, harmonising and enriching major European neuroimaging studies across the life span, we will merge fine-grained BCM health measures of more than 5000 individuals. Longitudinal brain imaging, genetic and health data are available for a major part, as well as cognitive and mental health measures for the broader cohorts, exceeding 27,000 examinations in total. By linking these data to other databases and biobanks, including birth registries, national and regional archives, and by enriching them with a new online data collection and novel measures, we will address the risk factors and protective factors of BCM health. We will identify pathways through which risk and protective factors work and their moderators. Exploiting existing European infrastructures and initiatives, we hope to make major conceptual, methodological and analytical contributions towards large integrative cohorts and their efficient exploitation. We will thus provide novel information on BCM health maintenance, as well as the onset and course of BCM disorders. This will lay a foundation for earlier diagnosis of brain disorders, aberrant development and decline of BCM health, and translate into future preventive and therapeutic strategies. Aiming to improve clinical practice and public health we will work with stakeholders and health authorities, and thus provide the evidence base for prevention and intervention.",
keywords = "Dementia, Economics and psychiatry, Epidemiology, MRI, Neurodevelopment, Psychiatric disorder",
author = "Walhovd, {Kristine B.} and Fjell, {Anders M.} and Ren{\'e} Westerhausen and Lars Nyberg and Ebmeier, {Klaus P.} and Ulman Lindenberger and David Bartr{\'e}s-Faz and Baar{\'e}, {William F.C.} and Siebner, {Hartwig R.} and Richard Henson and Drevon, {Christian A.} and {Str{\o}mstad Knudsen}, {Gun Peggy} and Lj{\o}sne, {Isabelle Budin} and Penninx, {Brenda W.J.H.} and Paolo Ghisletta and Ole Rogeberg and Lorraine Tyler and Lars Bertram and {Lifebrain Consortium}",
year = "2018",
month = "4",
day = "1",
doi = "10.1016/j.eurpsy.2017.12.006",
language = "English",
volume = "50",
pages = "47--56",
journal = "European Psychiatry",
issn = "0924-9338",
publisher = "Elsevier Masson",

}

Walhovd, KB, Fjell, AM, Westerhausen, R, Nyberg, L, Ebmeier, KP, Lindenberger, U, Bartrés-Faz, D, Baaré, WFC, Siebner, HR, Henson, R, Drevon, CA, Strømstad Knudsen, GP, Ljøsne, IB, Penninx, BWJH, Ghisletta, P, Rogeberg, O, Tyler, L, Bertram, L & Lifebrain Consortium 2018, 'Healthy minds 0–100 years: Optimising the use of European brain imaging cohorts (“Lifebrain”)' European Psychiatry, vol. 50, pp. 47-56. https://doi.org/10.1016/j.eurpsy.2017.12.006

Healthy minds 0–100 years : Optimising the use of European brain imaging cohorts (“Lifebrain”). / Walhovd, Kristine B.; Fjell, Anders M.; Westerhausen, René; Nyberg, Lars; Ebmeier, Klaus P.; Lindenberger, Ulman; Bartrés-Faz, David; Baaré, William F.C.; Siebner, Hartwig R.; Henson, Richard; Drevon, Christian A.; Strømstad Knudsen, Gun Peggy; Ljøsne, Isabelle Budin; Penninx, Brenda W.J.H.; Ghisletta, Paolo; Rogeberg, Ole; Tyler, Lorraine; Bertram, Lars; Lifebrain Consortium.

In: European Psychiatry, Vol. 50, 01.04.2018, p. 47-56.

Research output: Contribution to journalShort surveyAcademicpeer-review

TY - JOUR

T1 - Healthy minds 0–100 years

T2 - Optimising the use of European brain imaging cohorts (“Lifebrain”)

AU - Walhovd, Kristine B.

AU - Fjell, Anders M.

AU - Westerhausen, René

AU - Nyberg, Lars

AU - Ebmeier, Klaus P.

AU - Lindenberger, Ulman

AU - Bartrés-Faz, David

AU - Baaré, William F.C.

AU - Siebner, Hartwig R.

AU - Henson, Richard

AU - Drevon, Christian A.

AU - Strømstad Knudsen, Gun Peggy

AU - Ljøsne, Isabelle Budin

AU - Penninx, Brenda W.J.H.

AU - Ghisletta, Paolo

AU - Rogeberg, Ole

AU - Tyler, Lorraine

AU - Bertram, Lars

AU - Lifebrain Consortium

PY - 2018/4/1

Y1 - 2018/4/1

N2 - The main objective of “Lifebrain” is to identify the determinants of brain, cognitive and mental (BCM) health at different stages of life. By integrating, harmonising and enriching major European neuroimaging studies across the life span, we will merge fine-grained BCM health measures of more than 5000 individuals. Longitudinal brain imaging, genetic and health data are available for a major part, as well as cognitive and mental health measures for the broader cohorts, exceeding 27,000 examinations in total. By linking these data to other databases and biobanks, including birth registries, national and regional archives, and by enriching them with a new online data collection and novel measures, we will address the risk factors and protective factors of BCM health. We will identify pathways through which risk and protective factors work and their moderators. Exploiting existing European infrastructures and initiatives, we hope to make major conceptual, methodological and analytical contributions towards large integrative cohorts and their efficient exploitation. We will thus provide novel information on BCM health maintenance, as well as the onset and course of BCM disorders. This will lay a foundation for earlier diagnosis of brain disorders, aberrant development and decline of BCM health, and translate into future preventive and therapeutic strategies. Aiming to improve clinical practice and public health we will work with stakeholders and health authorities, and thus provide the evidence base for prevention and intervention.

AB - The main objective of “Lifebrain” is to identify the determinants of brain, cognitive and mental (BCM) health at different stages of life. By integrating, harmonising and enriching major European neuroimaging studies across the life span, we will merge fine-grained BCM health measures of more than 5000 individuals. Longitudinal brain imaging, genetic and health data are available for a major part, as well as cognitive and mental health measures for the broader cohorts, exceeding 27,000 examinations in total. By linking these data to other databases and biobanks, including birth registries, national and regional archives, and by enriching them with a new online data collection and novel measures, we will address the risk factors and protective factors of BCM health. We will identify pathways through which risk and protective factors work and their moderators. Exploiting existing European infrastructures and initiatives, we hope to make major conceptual, methodological and analytical contributions towards large integrative cohorts and their efficient exploitation. We will thus provide novel information on BCM health maintenance, as well as the onset and course of BCM disorders. This will lay a foundation for earlier diagnosis of brain disorders, aberrant development and decline of BCM health, and translate into future preventive and therapeutic strategies. Aiming to improve clinical practice and public health we will work with stakeholders and health authorities, and thus provide the evidence base for prevention and intervention.

KW - Dementia

KW - Economics and psychiatry

KW - Epidemiology

KW - MRI

KW - Neurodevelopment

KW - Psychiatric disorder

UR - http://www.scopus.com/inward/record.url?scp=85044785779&partnerID=8YFLogxK

U2 - 10.1016/j.eurpsy.2017.12.006

DO - 10.1016/j.eurpsy.2017.12.006

M3 - Short survey

VL - 50

SP - 47

EP - 56

JO - European Psychiatry

JF - European Psychiatry

SN - 0924-9338

ER -